Health

Akeso Announced First Patient Dosed in Phase 3 Trial of Ivonescimab versus Tislelizumab for First-line Treatment of Squamous NSCLC

HONG KONG, Aug. 18, 2023 /PRNewswire/ -- Akeso Inc. ("Akeso", 9926. HK) announced today that the first patient has been dosed in a head-to-head phase III trial of ivonescimab, a potential first-in-class investigational PD-1/VEGF bi-specific antibody discovered by Akeso. The Phase III trial will e...

2023-08-18 20:00 6080

VIGILL Triumphs as "Excellence in Women's Intimate Hygiene Products Brand" at The LICTA 2022 Awards

KUALA LUMPUR, Malaysia, Aug. 18, 2023 /PRNewswire/ -- VIGILL, Taiwan's leading women's intimate care brand, proudly announces its recognition as the "Excellence in Women's Intimate Hygiene Products Brand" at the 5th Lang International Corporate Titan Awards (LICTA 2022) inMalaysia. VIGILL stands ...

2023-08-18 19:15 5032

Inmagene's anti-OX40 mAb demonstrated an extended half-life and a favorable safety profile in a Phase I study

* IMG-007 has the potential to provide Q12W or less frequent dosing based on an extended half-life * IMG-007 has demonstrated a favorable safety profile, consistent with a silenced ADCC function via bioengineering * IMG-007 is being evaluated in two global proof-of-concept trials  SAN DIEGO,...

2023-08-18 19:00 4645

Nature-inspired pressure sensing technology aims to transform healthcare and surgical robots

NUS researchers take a leaf out of nature's book to develop 'eAir' — an aero-elastic sensor that revolutionises the way pressure is detected SINGAPORE, Aug. 18, 2023 /PRNewswire/ -- Researchers at the National University of Singapore (NUS) have developed a novel aero-el...

2023-08-18 17:54 1684

United Imaging Healthcare delivers its 2023 Half-Year report, with revenue growth of 26.35% in the first half of 2023

SHANGHAI, Aug. 18, 2023 /PRNewswire/ -- United Imaging Healthcare (SSE:688271), a global innovator in cutting-edge medical imaging and radiotherapy equipment, has unveiled its highly anticipated 2023 half-year report, revealing robust growth. The report indicates that the company achieved5.27 bil...

2023-08-18 17:29 2586

JinMed (NASDAQ: ZJYL) Rings the Nasdaq Stock Market Closing Bell on August 17

CHANGZHOU, China, Aug. 17, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ: ZJYL), the world's leading provider of rehabilitation equipment, rang the bell at the New York Stock Exchange by its Chairman and CEOWang Erqi on August 17, to celebrate the Com...

2023-08-18 11:36 4143

QiLu Pharmaceutical's Iruplinalkib Phase III INSPIRE Study Researched Primary Endpoint and was Selected for 2023 WCLC Oral Presentation

JINAN, China, Aug. 18, 2023 /PRNewswire/ -- August 16, 2023, at the 2023 World Conference on Lung Cancer (WCLC), the complete list of selected abstracts was announced, among which QiLu Pharmaceutical's iruplinalkib phase III clinical trial (INSPIRE) results were chosen for oral presentation at th...

2023-08-18 09:50 2385

Thrombotic AEs of Hemlibra (emicizumab) were 2.8 times more frequent than those of FVIII replacements.

* Analyzed the FDA FAERS data…to compare the thrombotic AEs of Hemlibra vs. FVIII replacements. YONGIN, South Korea, Aug. 17, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced on August 17, 2023 that it has presented the results of analyzing and...

2023-08-18 08:58 2233

Everest Medicines' Partner Calliditas Therapeutics Announces Full Results From NefIgArd Phase 3 Trial published in The Lancet

SHANGHAI, Aug. 18, 2023 /PRNewswire/ -- Everest Medicines' (HKEX 1952.HK, "Everest", or the "Company") partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") announced the publication inThe Lancet of the full data from the NeflgArd Phase 3 trial with Nefecon® in...

2023-08-18 08:41 2341

The Global Medical Robotics Conference 2023: A Deep Dive into China's Booming Surgical Robotics Landscape

BEIJING, Aug. 17, 2023 /PRNewswire/ -- The groundbreaking Global Medical Robotics Conference 2023 will be held inBeijing on September 8, 2023. This unprecedented event brings together a wide range of surgical robotics from around the world, making it the first of its kind globally. The conference...

2023-08-18 02:08 1653

BoomerangFX expands into Australian Market Driven by Growing Demand for Aesthetic Medicine Services in Asia Pacific

Responding to Growing Customer Demand – Cloud-Based Clinic Software, Digital Marketing & eLearning Provider Makes Significant Advances in the Australian Market TORONTO and MIAMI, Aug. 17, 2023 /PRNewswire/ -- BoomerangFX, a global provider of Software as a Service (SaaS), specializing in compreh...

2023-08-18 00:01 1494

Neurophth Announces First Patient Dosed in Phase I/II Clinical Trial of Second Gene Therapy

WUHAN, China and SAN DIEGO, Aug. 17, 2023 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurophth") announced today that the first patient has been dosed in the international multi-region, multi-center Phase I/II clinical trial for the treatment of Leber hereditary optic neuropathy caused byND1 ...

2023-08-17 21:00 1389

Minghui Pharmaceutical Inc. Announces First Patient Enrollment in the Phase 3 Clinical Study of MH004 Cream for Treatment of Mild to Moderate Atopic Dermatitis

SHANGHAI, HANGZHOU, China and WILMINGTON, Del., Aug. 17, 2023 /PRNewswire/ -- Minghui Pharmaceutical, Inc., a leading clinical-stage biopharmaceutical company, today announced the successful enrollment of the first patient in the phase 3 clinical study for MH004 Cream targeting mild to moderate a...

2023-08-17 19:00 4390

I-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updates

* Significant progress made year-to-date on key clinical assets: ‐         Uliledlimab (CD73 antibody): Encouraging early results were presented at ASCO 2023 ‐         Givastomig (Claudin 18.2 x 4-1BB bispecific antibody): Topline Phase 1 data with promising early efficacy signals, including pat...

2023-08-17 18:00 4298

2023WCLC Oral Presentation | Molecular Analysis Validates the Effectiveness of Tumor Tissue-Based and Plasma ctDNA Testing in Identifying NSCLC Patients with EGFR Exon20ins Eligible for Treatment with Sunvozertinib

* A high concordance was observed between tumor tissue-based and plasma circulating tumor DNA (ctDNA) testing in detecting EGFR exon 20 insertion (Exon20ins) mutations. * Both tumor tissue-based and plasma ctDNA testing can be used to identify patients who may benefit from treatment with su...

2023-08-17 17:10 2157

Capco's Singapore 2023 insurance survey highlights opportunities for insurers to use innovative data and personalization strategies to meet evolving customer needs

Consumers favor more personalized products and are willing to share additional personal data with insurers to secure benefits, including an enhanced claims process and cheaper premiums Insurers need to consider long-established customer imperatives such as affordability, value for money and a pr...

2023-08-17 10:00 1881

Novo Holdings participates in $290m strategic financing of Sangon Biotech

COPENHAGEN, Denmark, Aug. 17, 2023 /PRNewswire/ -- Novo Holdings, a leading international life science investor, today announced it has participated in a $290 million (USD) strategic financing round of Sangon Biotech. Sangon is a leading provider of life science tools and services, enabling scient...

2023-08-17 09:44 2151

TraceLink Collaborates with GS1 US to Author GS1 US Addendum Guidance and XML Examples for GS1 US DSCSA Implementation Guideline R1.3 to Support EPCIS Data Exchange

Publication of the GS1 standard guidelines and technical examples provide a strong foundation to help companies accelerate their network connectivity and EPCIS-based sTI/TS data exchange to meet forthcomingNovember 2023 DSCSA deadlines. BOSTON, Aug. 17, 2023 /PRNewswire/ -- TraceLink Inc., the l...

2023-08-17 09:35 1345

Innovent Announces the NMPA Approval of SINTBILO® (Tafolecimab Injection) for the Treatment of Adult Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...

2023-08-17 08:00 3150

Global Leading Health Company JUNG KWAN JANG Participates in "William Jones Cup" after 4-year Gap

TAIPEI, Aug. 17, 2023 /PRNewswire/ -- Korea Ginseng Corporation's JUNG KWAN JANG basketball team will compete in the William Jones Cup International Basketball Tournament to be held inTaiwan from August 12. They will represent South Korea as the men's basketball team and compete against foreign t...

2023-08-17 08:00 2449
1 ... 178179180181182183184 ... 847